The fairness of increasing cancer research funding in FY2010 comes into question during House and Senate hearings. See my post of May 23, 2009: Senator Harkin and the Senate Appropriations subcommittee on Labor, Health and Human Services, and Education Hold Hearings on the Budget Allocations to the NCI for Cancer Research Two leading appropriators in [...]
On Thursday the Senate Appropriations subcommittee on Labor, Health and Human Services, and Education held its FY 2010 NIH budget hearing. There were two particular items of note for the cancer community. When discussing the NIH funding which was received through the economic stimulus package, Senator Harkin questioned if the current two years the NIH [...]
Getting increased funding for the Department of Defense (DOD) Peer Review Prostate Cancer Research Program (PCRP) is one of the goals that have been identified by a coalition of many of the prostate cancer advocacy and support organizations. The funding for the program has remained stagnant for a number of years despite the fact that [...]
I have been talking about the need to increase the funding levels for the Department of Defense (DOD) Peer Review Prostate Cancer Research Program (PCRP) for a long period. This program has proven itself to be the single most valuable government funded prostate cancer research program. The program is designed to fund research projects that [...]
Shocking news, under the President Obama's latest budget request, the prostate cancer program at CDC would receive only a 0.23% increase. The FDA would receive an appropriation of $2.35 billion, an increase of $295 million (14.4%), once again prostate cancer has been left in the dust! Joel T Nowak MA, MSW